000 | 01952 a2200481 4500 | ||
---|---|---|---|
005 | 20250516235050.0 | ||
264 | 0 | _c20150115 | |
008 | 201501s 0 0 eng d | ||
022 | _a1522-1547 | ||
024 | 7 |
_a10.1152/ajpgi.00258.2014 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aToti, Luca | |
245 | 0 | 0 |
_aGastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis. _h[electronic resource] |
260 |
_bAmerican journal of physiology. Gastrointestinal and liver physiology _cNov 2014 |
||
300 |
_aG1013-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBiomarkers _xmetabolism |
650 | 0 | 4 |
_aCholine O-Acetyltransferase _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aDopamine Antagonists _xadministration & dosage |
650 | 0 | 4 |
_aDopamine beta-Hydroxylase _xmetabolism |
650 | 0 | 4 |
_aDopaminergic Neurons _xdrug effects |
650 | 0 | 4 |
_aGastric Emptying _xdrug effects |
650 | 0 | 4 |
_aGastric Mucosa _xmetabolism |
650 | 0 | 4 |
_aGastroparesis _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicroinjections |
650 | 0 | 4 |
_aMyenteric Plexus _xdrug effects |
650 | 0 | 4 |
_aNitric Oxide Synthase Type I _xmetabolism |
650 | 0 | 4 | _aOxidopamine |
650 | 0 | 4 |
_aParkinsonian Disorders _xchemically induced |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aStomach _xdrug effects |
650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
650 | 0 | 4 |
_aSympathomimetics _xadministration & dosage |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
700 | 1 | _aTravagli, R Alberto | |
773 | 0 |
_tAmerican journal of physiology. Gastrointestinal and liver physiology _gvol. 307 _gno. 10 _gp. G1013-23 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajpgi.00258.2014 _zAvailable from publisher's website |
999 |
_c24243510 _d24243510 |